Biotech
Retro Biosciences
Retro Biosciences raises $1B Growth at $2B valuation
$1B
Total Raised
Growth
Latest Round
2021
Founded
150+
Employees
San Mateo, CA
1 min read
Quick Facts
Valuation
$2B
Latest Round Size
$1B
Latest Round Date
January 2025
Retro Biosciences: Growth Funding Round
Retro Biosciences has successfully raised $1B in Growth funding, reaching a valuation of $2B.
Company Overview
Extending healthy human lifespan
Funding Details
The Growth round was led by Sandro Salsano, with participation from Y Combinator.
Company Information
- Headquarters: San Mateo, CA
- Founded: 2021
- Employees: 150+
- Category: Biotech
Investment
Retro Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Sandro Salsano: Verified investor in Growth
- Y Combinator: Verified investor in Growth
Key Investors
Sandro Salsano
Lead Investor
Verified investor in Growth
Y Combinator
Investor
Verified investor in Growth
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min readβ’$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min readβ’$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min readβ’$250M